Lupin Limited has informed the Exchange regarding a press release dated October 13, 2025, titled "Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at theESMO Congress 2025".
Lupin Limited has informed the Exchange regarding a press release dated October 13, 2025, titled "Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at theESMO Congress 2025".